rxstat › Classes › Antiemetics And Antinauseants

Antiemetics And Antinauseants: shortage status in Canada

4 of the 7 antiemetics and antinauseants rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Granisetron Widespread shortage 2 of 2 reported products affected · est. return Aug 10, 2026 Fosaprepitant (Emend) Partial shortage 1 of 1 reported products affected · est. return Aug 14, 2026 Ondansetron (Zofran) Partial shortage 11 of 55 reported products affected · est. return Oct 30, 2026 Palonosetron (Aloxi) Partial shortage 1 of 2 reported products affected Aprepitant (Emend) Discontinued 0 of 2 reported products affected Aprepitant (Emend Tri-Pack) Discontinued 0 of 1 reported products affected Nabilone (Cesamet) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.